UA83790C2 - Применение sarp-1 для лечения и/или предупреждения фиброзных заболеваний - Google Patents
Применение sarp-1 для лечения и/или предупреждения фиброзных заболеванийInfo
- Publication number
- UA83790C2 UA83790C2 UA2003076266A UA2003076266A UA83790C2 UA 83790 C2 UA83790 C2 UA 83790C2 UA 2003076266 A UA2003076266 A UA 2003076266A UA 2003076266 A UA2003076266 A UA 2003076266A UA 83790 C2 UA83790 C2 UA 83790C2
- Authority
- UA
- Ukraine
- Prior art keywords
- sarp
- prevention
- treatment
- fibrotic diseases
- fibrosis
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000003176 fibrotic effect Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 102100030054 Secreted frizzled-related protein 2 Human genes 0.000 abstract 2
- 108050007987 Secreted frizzled-related protein 2 Proteins 0.000 abstract 2
- 208000001708 Dupuytren contracture Diseases 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 208000029523 Interstitial Lung disease Diseases 0.000 abstract 1
- 208000002260 Keloid Diseases 0.000 abstract 1
- 206010023330 Keloid scar Diseases 0.000 abstract 1
- 206010060932 Postoperative adhesion Diseases 0.000 abstract 1
- 206010039710 Scleroderma Diseases 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 210000001117 keloid Anatomy 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00126771 | 2000-12-06 | ||
| EP01118888 | 2001-08-17 | ||
| PCT/EP2001/013992 WO2002046225A2 (en) | 2000-12-06 | 2001-11-30 | Use of sarp-1 for the treatment and/or prevention of scleroderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83790C2 true UA83790C2 (ru) | 2008-08-26 |
Family
ID=26071647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003076266A UA83790C2 (ru) | 2000-12-06 | 2001-11-30 | Применение sarp-1 для лечения и/или предупреждения фиброзных заболеваний |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7341995B2 (ru) |
| EP (2) | EP1411970B1 (ru) |
| JP (1) | JP2004525869A (ru) |
| KR (1) | KR100804885B1 (ru) |
| CN (1) | CN1323716C (ru) |
| AT (1) | ATE359808T1 (ru) |
| AU (2) | AU2636602A (ru) |
| BG (1) | BG107941A (ru) |
| BR (1) | BR0115983A (ru) |
| CA (1) | CA2428092A1 (ru) |
| CY (1) | CY1107687T1 (ru) |
| CZ (1) | CZ20031855A3 (ru) |
| DE (1) | DE60128009T2 (ru) |
| DK (1) | DK1411970T3 (ru) |
| EA (1) | EA005973B1 (ru) |
| EE (1) | EE200300213A (ru) |
| ES (1) | ES2281463T3 (ru) |
| HK (1) | HK1068106A1 (ru) |
| HR (1) | HRP20030426A2 (ru) |
| HU (1) | HUP0302738A3 (ru) |
| IL (1) | IL156069A0 (ru) |
| MX (1) | MXPA03005027A (ru) |
| NO (1) | NO20032597L (ru) |
| NZ (1) | NZ525774A (ru) |
| PL (1) | PL365316A1 (ru) |
| PT (1) | PT1411970E (ru) |
| SK (1) | SK8472003A3 (ru) |
| UA (1) | UA83790C2 (ru) |
| WO (1) | WO2002046225A2 (ru) |
| YU (1) | YU45103A (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000070879A (ko) * | 1997-02-06 | 2000-11-25 | 브루스 엠. 에이센, 토마스 제이 데스로저 | 인간 에스디에프-5 단백질 및 조성물 |
| US7585840B2 (en) | 2002-04-10 | 2009-09-08 | Merck Serono S.A. | Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| PL372928A1 (en) * | 2002-04-10 | 2005-08-08 | Applied Research Systems Ars Holding N.V. | Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| US9046537B2 (en) * | 2003-09-22 | 2015-06-02 | Enzo Biochem, Inc. | Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain |
| SE0400489D0 (sv) * | 2004-02-27 | 2004-02-27 | Biovitrum Ab | Therapeutic proteins |
| HUE042689T2 (hu) | 2005-02-08 | 2019-07-29 | Genzyme Corp | TGFbéta elleni antitestek |
| JP5025646B2 (ja) * | 2005-11-08 | 2012-09-12 | 公益財団法人先端医療振興財団 | 虚血性心疾患の治療方法 |
| WO2009074637A1 (en) * | 2007-12-13 | 2009-06-18 | Merck Serono S.A. | Sarp-1 fusion proteins and uses thereof |
| BR112013023280A2 (pt) * | 2011-03-11 | 2017-09-19 | Celgene Corp | uso de 3-(5-amino-2-metil-4-oxoquinazolina-3(4h)-il)-piperidina-2,6-diona em tratamento de doenças inflamatórias e relacionadas ao sistema imune |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2855189A (en) * | 1988-01-25 | 1989-07-27 | Baker Cummins Dermatologicals, Inc. | Method of treating fibrotic disorders |
| US5266575A (en) * | 1991-11-06 | 1993-11-30 | Minnesota Mining And Manufacturing Company | 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines |
| US5747639A (en) * | 1996-03-06 | 1998-05-05 | Amgen Boulder Inc. | Use of hydrophobic interaction chromatography to purify polyethylene glycols |
| TW555765B (en) * | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
| WO1998013493A2 (en) * | 1996-09-24 | 1998-04-02 | Lxr Biotechnology, Inc. | A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| US5858715A (en) * | 1997-01-29 | 1999-01-12 | Incyte Pharmaceuticals, Inc. | Human apoptosis-associated protein |
| KR20000070879A (ko) * | 1997-02-06 | 2000-11-25 | 브루스 엠. 에이센, 토마스 제이 데스로저 | 인간 에스디에프-5 단백질 및 조성물 |
| ATE327254T1 (de) * | 1998-10-16 | 2006-06-15 | Biogen Idec Inc | Interferon-beta fusionsproteine und deren verwendungen |
-
2001
- 2001-11-30 CA CA002428092A patent/CA2428092A1/en not_active Abandoned
- 2001-11-30 NZ NZ525774A patent/NZ525774A/xx unknown
- 2001-11-30 PT PT01995681T patent/PT1411970E/pt unknown
- 2001-11-30 ES ES01995681T patent/ES2281463T3/es not_active Expired - Lifetime
- 2001-11-30 WO PCT/EP2001/013992 patent/WO2002046225A2/en active Search and Examination
- 2001-11-30 HU HU0302738A patent/HUP0302738A3/hu unknown
- 2001-11-30 IL IL15606901A patent/IL156069A0/xx unknown
- 2001-11-30 DE DE60128009T patent/DE60128009T2/de not_active Expired - Lifetime
- 2001-11-30 EP EP01995681A patent/EP1411970B1/en not_active Expired - Lifetime
- 2001-11-30 JP JP2002547961A patent/JP2004525869A/ja active Pending
- 2001-11-30 CZ CZ20031855A patent/CZ20031855A3/cs unknown
- 2001-11-30 DK DK01995681T patent/DK1411970T3/da active
- 2001-11-30 SK SK847-2003A patent/SK8472003A3/sk not_active Application Discontinuation
- 2001-11-30 UA UA2003076266A patent/UA83790C2/ru unknown
- 2001-11-30 PL PL01365316A patent/PL365316A1/xx not_active Application Discontinuation
- 2001-11-30 YU YU45103A patent/YU45103A/sh unknown
- 2001-11-30 CN CNB018223389A patent/CN1323716C/zh not_active Expired - Fee Related
- 2001-11-30 KR KR1020037007278A patent/KR100804885B1/ko not_active IP Right Cessation
- 2001-11-30 EP EP07103384A patent/EP1806144A3/en not_active Withdrawn
- 2001-11-30 MX MXPA03005027A patent/MXPA03005027A/es active IP Right Grant
- 2001-11-30 AT AT01995681T patent/ATE359808T1/de active
- 2001-11-30 EE EEP200300213A patent/EE200300213A/xx unknown
- 2001-11-30 EA EA200300639A patent/EA005973B1/ru not_active IP Right Cessation
- 2001-11-30 AU AU2636602A patent/AU2636602A/xx active Pending
- 2001-11-30 AU AU2002226366A patent/AU2002226366B2/en not_active Ceased
- 2001-11-30 BR BR0115983-6A patent/BR0115983A/pt not_active IP Right Cessation
- 2001-11-30 US US10/432,256 patent/US7341995B2/en not_active Expired - Fee Related
-
2003
- 2003-05-23 HR HR20030426A patent/HRP20030426A2/hr not_active Application Discontinuation
- 2003-06-06 NO NO20032597A patent/NO20032597L/no not_active Application Discontinuation
- 2003-06-25 BG BG107941A patent/BG107941A/bg unknown
-
2005
- 2005-03-04 HK HK05101882A patent/HK1068106A1/xx not_active IP Right Cessation
-
2007
- 2007-06-28 CY CY20071100851T patent/CY1107687T1/el unknown
- 2007-12-20 US US11/961,033 patent/US7655628B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA56989C2 (ru) | ФИЗИОЛОГИЧЕСКИ АКТИВНЫЙ ПЕГ-КОНЬЮГАТ a-ИНТЕРФЕРОНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИММУНОМОДУЛЯТОРНЫХ ЗАБОЛЕВАНИЙ | |
| WO2002087563A3 (en) | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions | |
| IL233545A0 (en) | Immunogenic preparations for the prevention and treatment of inflammatory bowel disease | |
| WO2003000241A3 (de) | Neue arzneimittelkompositionen auf der basis von anticholinergika; corticosteroiden und betamimetika zur behandlung von entzündlichen und/oder obstruktiven atemwegserkrankungen | |
| BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| HUP0102899A3 (en) | Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract | |
| BG108443A (en) | Substituted oxazoliidinones for combinational therapy | |
| CA2293823A1 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| CA2292359A1 (en) | Novel azalides and methods of making same | |
| AU6286294A (en) | Guanidine derivatives useful in therapy | |
| CA2289717A1 (en) | Novel therapy for constipation | |
| EP1461024A4 (en) | TREATMENT OF WOUNDS AND COMPOSITIONS USED | |
| WO1999043344A3 (en) | Matrix protein compositions for wound healing | |
| AU2002248319A1 (en) | Pharmaceutical composition for the prevention and treatment of scar tissue | |
| UA83790C2 (ru) | Применение sarp-1 для лечения и/или предупреждения фиброзных заболеваний | |
| WO2001024783A3 (de) | Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| AU2002227052A1 (en) | Treatments for neurogenetic disorders, impulse control disorders, and wound healing | |
| WO2001074394A8 (en) | New combination of a betablocker and a cholesterol-lowering agent | |
| IL162259A0 (en) | Benzazole derivatives in scleroderma | |
| WO2003049667A3 (en) | The method of treating cancer | |
| WO2000059490A8 (en) | Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions | |
| CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
| CA2399709A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers | |
| WO2003007876A3 (en) | N-fatty acid-amino acid conjugates and therapeutic uses | |
| WO2001030334A3 (en) | 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation |